Isodiol International Inc. (CSE:ISOL) (OTCQB:ISOLF) today announced two new products. RapidCBD and Iso-Sport are to be stocked in Holland & Barrett. ISOL stock jumped 34% as a result.
Two New Hemp-Based Products
Ensuring it has a head start in the CBD product race, Isodiol is partnering up with Holland & Barrett, the UK's leading health and wellness retailer. Isodiol International's products are being exposed to 1,300 stores, and 10 million loyalty members across the UK and the Republic of Ireland. Though sales are currently limited to online, it is expected that RapidCBD and Iso-Sport will be available in up to 800 brick and mortar stores by the end of the month.
The cannabis company's CEO, Marcos Agramont, has this to say about the exciting joint venture: “Isodiol has been the pioneer of many firsts in the hemp-based consumer packaged goods (CPG) industry. This one is special because it provides equal access to quality CBD products for an entire demographic of consumers who have a pre-existing relationship with a trusted vendor.”
The RapidCBD and Iso-Sport food supplement and skin care range are formulated with the company’s proprietary ISO99. The hemp and botanical blends were specifically created for UK and EU consumers and promote both physical and mental health benefits.
>> Pot Stock Market Game: The Best and Worst Cannabis Traders Today
Isodiol Entering into the UK Market
Getting its foot in the door of the EU market is significant for this Canadian company. Isodiol already has products and retail outlets across the US and Canada but is setting itself up for a serious advantage in a burgeoning market. Though the EU and the UK are highly regulated and pose challenges in creating compliant CBD products, VP of Business Development Graham Boylan believes the juice is worth the squeeze: "the opportunities to provide Isodiol’s pioneering hemp-based consumer packaged goods . . . outweigh those challenges."
ISOL Stock Up
At the time of writing, the company's announcement led to a stock jump of 34% with shares selling at $1.69 on the CSE. ISOL has had a busy few weeks. In February, the company announced its CBD retail outlets, and at the beginning of March, Isodiol Q3 results showed revenue in excess of $7.1 million USD.
In other exciting news for the company, Isodiol also announced that it is exhibiting at the ASD Market Week, the most comprehensive B2B trade show for consumer merchandise. Isodiol will be promoting its Fast CBD Relief brand, which is the company's flagship product.
Featured Image: Canva
